• 대한본초학회지
• /
• 제33권1호
• /
• pp.9-15
• /
• 2018

Objectives : The root bark of Dictamnus dasycarpus has been frequently used to treat patients with skin diseases in Korea. Recently, wild root of D. dasycarpus are reported to induce liver injury. Methods : Traditional uses of D. dasycarpus for skin diseases were analysed bibliographically. In addition, reported cases were collected and analysed using pubmed and national digital library. Results : In taiwan, D. dasycarpus revealed to be one of major herbs for skin diseases and many researchers in worldwide had reported its dermatological efficacies. Reported cases related in liver injury described that hepatocellular or cholestatic liver injury were seen in patients eating wild root of D. dasycarpus. In addition, 6 cases in worldwide and 1 case in Korea showed that patients with drug induced liver injury (DILI) ingested not root bark of D. dasycarpus but prescriptions containing root bark of D. dasycarpus. These mean that wild root of D. dasycarpus (Bongsam or Bongwhangsam) was estimated to be closely related in DILI. Whereas, it was difficult to confirm direct correlation between root bark of D. dasycarpus used as herbal medicine by doctor of Korean medicine and DILI. Conclusions : these results imply that wild root of D. dasycarpus is closely related in DILI and strong recommendation not to take it without consultation by experts is needed. In addition, although there are no evidences of direct correlation between root bark of D. dasycarpus and DILI, doctor of Korean medicines should pay attention to use root bark of D. dasycarpus in their clinics.

• 대한본초학회지
• /
• 제33권1호
• /
• pp.71-76
• /
• 2018

Objectives : This study was performed to investigate the single oral toxicity of HBX-6 in Sprague-Dawley (SD) rats. Methods : Twenty SD rats were randomly assigned to four groups of 5 rats each and were administrated singly to female and male SD rats, as an oral dose of 2000 mg/kg. HBX-6 is a newly combined Korean herbal medicine formula 30 % Ethanol extract derived from The Dongui Bogam. Now we are developing the prescription for the aim of improving benign prostatic hyperplasia (BPH) without undesirable side effects. HBX-6 is composed of nine medicinal herbs: Aconiti Lateralis Radix Preparata, Corni Fructus, Cistanchis Herba, Psoraleae Semen, Dendrobii Herba, Morindae Radix, Cuscutae Semen, Trigonellae Semen, Foeniculi Fructus. Animals were monitored for the mortality and changes in the body weight, clinical signs, gross observation and necropsy findings for the 14 days according to "Standard for Toxicity Study of Pharmaceuticals" of Korea Food and Drug Administration (KFDA) guideline and "Acute Oral Toxicity - Fixed Dose Procedure" of OECD Test Guideline. Results : We could not find any mortality. Compared with the control group, significant weight change was not observed in the experimental group. After administration, the more common symptoms were not observed. There were no gross abnormalities in all cases. Conclusions : Taken together, these results suggest that the approximate lethal dose of HBX-6 in both female and male SD rats were considered as over 2000 mg/kg.

• 미생물학회지
• /
• 제47권3호
• /
• pp.241-248
• /
• 2011

식품의 상품성과 보존을 위하여 사용하는 합성 첨가물이 소비자들의 소비 습관의 변화와 첨가물의 안전성에 대한 사회적 쟁점화로 천연의 소재를 활용한 다양한 연구와 조사가 진행되고 있다. 본 연구에서도 천연물 중 한의학의 소재로 사용되는 생약제제 79종을 사용하여 식품 중 상품성이 훼손된 음료에서 분리한 세균에 대한 항균성을 조사하였다. 13종의 Bacillus sp.와 3종의 Paenibacillus sp.에 대한 메탄올 추출물의 항균성을 조사한 결과 43종의 생약제제가 분리한 세균에 대한 항균성을 나타내었다. 이 중 8종의 한약재를 선별하고 이들을 대상으로 물, 에탄올, 메탄올과 에틸아세테이트를 추출 용매로 하여 항균성을 조사한 결과 오매, 오배자와 황련이 분리된 세균에 대한 항균성이 우수한 것으로 조사되었으며 특히 물과 에탄올을 사용한 경우에 우수한 항균성을 나타내어 이 결과를 바탕으로 이들 소재를 활용한 천연보존료의 개발 가능성을 확인할 수 있었다. 특히 다른 생약제제와 비교할 때 오매에 대한 연구가 상대적으로 미진한 것으로 판단되어 향후 지속적인 연구를 통한 제품의 개발도 가능할 것으로 판단하였다.

• 대한상한금궤의학회지
• /
• 제14권1호
• /
• pp.1-26
• /
• 2022

Objectives: We aimed to confirm the safety and effectiveness of the decoction of Sibjo-tang, which is a powder type purgative. In addition, we checked whether the '發作' of 『Shanghanlun』 can be interpreted to have the same meaning as "seizure" in English. By confirming these objectives, we intend to lead the progress in the application of Sibjo-tang and to expand the clinical application of the 152nd provision and Sibjo-tang. Methods: We analyzed the medical records of patients who visited Apgujeongjeongin Oriental Clinic and Almyeon Oriental Clinic for seizures. We confirmed side effects in patients who took Sibjo-tang for a long time. Sibjo-tang was prepared as a hot water extract by using 5 g each of Euphorbiae Pekinensis Radix, Eurphobiae Kansui Radix, and Genkwae Flos and 15 g of Zizyphi Fructus. The "seizure" recorded in the 152nd provision was interpreted through the shape analysis of Oracle bone scripts. The seizure frequency of patients diagnosed with epilepsy after taking Sibjo-tang was compared, and we analyzed other symptoms and psychosocial conditions associated with seizures at the first episode. Results: No side effects were found in 7 patients who took Sibjo-tang for 16.57 ± 14.10 months. Seizures were eliminated in 6 cases while taking Sibjo-tang and significantly decreased in 1 case. Frequent indigestion (in 7 cases), mild exhaustion (in 5 cases), and inferiority complex (in 5 cases) were identified as accompanying pathogenic conditions. The "seizure" in the 152nd provision was interpreted as "a state of being stabbed by a sharp substance in clothes", confirming a deep connection with epileptic seizures. Conclusions: The results suggest that using a decoction of Sibjo-tang is safe and efficacious. In addition, the necessity of conducting an advanced study on epileptic seizures accompanied by frequent indigestion using Sibjo-tang was confirmed.

• Journal of Acupuncture Research
• /
• 제33권3호
• /
• pp.197-205
• /
• 2016

Objectives : To report the clinical application and safety of Traditional Korean Medical treatment for patients with low back pain during pregnancy. Methods : Three patients who suffered from low back pain during pregnancy were treated with acupuncture, pharmacopuncture, moxibustion, and herbal medicine for 12 to 21 days. Numeric rating scale (NRS) of low back pain and Oswestry Disability Index (ODI) were checked to measure the outcome. A liver function and renal function test was carried out to identify any drug-induced liver or renal injury, and any adverse events were monitored thoroughly until delivery. Results : Low back pain reduced on NRS in all cases, and no serious adverse effects were found in the patients or infants. Conclusion : This study suggests that Traditional Korean Medical treatment is a candidate therapy for relieving low back pain during pregnancy, and also is safe for both patients and infants.

• 한국자원식물학회지
• /
• 제34권1호
• /
• pp.52-58
• /
• 2021

백출의 기원 감별 및 품질기준 설정을 위하여 atractylenolide III과 atracylodin을 지표성분으로 설정하였다. HPLC를 이용하여 선정된 지표물질인 atractylenolide III과 atracylodin의 특이성, 직선성, 범위, 검출한계, 정량한계, 정확성, 정밀성에 대한 평가를 실시한 결과 모두 양호한 결과가 나타나 분석법에 문제는 없었으며, 백출과 창출을 각각 분석한 결과 위품인 창출에서만 atracylodin이 검출이 되어 위품 구별이 가능한 지표물질로 손색이 없었다.

• Environmental Analysis Health and Toxicology
• /
• 제31권
• /
• pp.16.1-16.9
• /
• 2016

Objectives Banha-sasim-tang (BST), which consists of seven different herbs, is one of the most popular herbal formulae for treating gastrointestinal disorders in Eastern Asia. The commonly used herbal medicine is often co-administered with other therapeutic drugs, which raises the possibility of herb-drug interactions and may modify the clinical safety profile of therapeutic drugs. Methods We investigated the potential herb-drug interactions between BST extract and midazolam (MDZ) in mice. The area under the plasma concentration-time curve (AUC) of MDZ and 1'-hydroxymidazolam (1'-OH-MDZ) was evaluated for both oral and intraperitoneal administration of MDZ, following oral administration of BST (0.5 and 1 g/kg). Results It was found that the AUC of MDZ and 1'-OH-MDZ was lower in case of oral administration of MDZ. Administration of BST extract was not associated with hepatic cytochrome P450 activity. BST extract induced a strong reduction in pH and it has been reported that oral mucosal absorption of MDZ is lower at low pH. The decreased absorption rate of MDZ might be caused by the ingredients of BST and may not be related to other factors such as increased excretion of MDZ by P-glycoprotein. Conclusions The altered pharmacokinetics of midazolam caused by co-administration with BST in vivo could be attributed to a decrease in pH and subsequent reduction of MDZ absorption rate.

• 대한한의학방제학회지
• /
• 제28권2호
• /
• pp.169-177
• /
• 2020

Objectives : This experiment was designed to assess the single oral toxicity of Ethanol Extract Inulae Flos (IF) ethanol extracts. IF is one of the important herbs to remove phlegmy which is the viscous turbid pathological product that can accumulate in the body, causing a variety of diseases. Nevertheless, there has been a lack of research on the pharmacology toxicity of IF. Methods : In this study, IF was orally administered to 5 weeks ICR mice as an oral dose of 2,000 or 3,000 or 5,000 mg/kg. The condition of the mice was observed for 14 days and their weights were measured every two days. Results : None of the mice died for 14 days. The abnormal clinical symptoms and anatomical signs of toxicity were not found in any treatment groups. The gain of net body weight was observed. There was also no significant difference in the organ weight. The serum biochemistry and hematological analysis showed a decrease in BUN, red blood cells, white blood cells and platelets although within the normal ranges. Conclusions : These results suggest that the 50% lethal dose of IF is more than 5,000 mg/kg. This could be thought that IF is a safe drug without acute toxicity and side effects. However, IF showed some weight loss and change in blood test, so it will need to be careful when using it for high doses.

• 한국환경농학회지
• /
• 제40권4호
• /
• pp.353-358
• /
• 2021

본 연구는 한약재 길경 중 Imidazole계 살균제 prochloraz 및 그 대사체 2,4,6-T의 잔류분석법을 확립하였다. 한약재 중 길경을 대표 시료로 선정하고 GC-ECD를 이용한 prochloraz 정량 시험법을 개발하였다. 한약재 길경 중 prochloraz 잔류물을 acetone로 추출하고, dichloromethane로 분배하고 pyridine hydoxyde를 이용하여 분해한 뒤, 이온억압 분배과정 후, NH₂ cartridge로 정제하였다. 한약재 길경 중 prochloraz의 경우 정량한계는 0.04 mg/kg으로 결정되었으며, MLOQ 수준의 회수율은 89.7%, MLOQ 10배 수준에서는 82.5%의 우수한 회수율을 보였으며, 분석오차는 최대 2.8%로 재현성 역시 양호하였다. 2,4,6-T의 경우 정량한계는 0.02 mg/kg으로 결정되었으며, MLOQ 수준의 회수율은 83.0%, MLOQ 10배 수준에서는 82.1%의 우수한 회수율을 보였으며, 분석오차는 최대 2.8%로 재현성 역시 양호하였다. 본 연구에서 확립한 prochloraz 및 그 대사체 2,4,6-T의 잔류분석법은 국내·외 한약재의 잔류농약 검사 및 분석에 적용 가능할 것으로 기대된다.

• 대한한방내과학회지
• /
• 제43권4호
• /
• pp.656-679
• /
• 2022

Objectives: The aims of this study were to evaluate the fidelity of stroke stage reporting, the timeliness of the outcome measures, and the use of the core outcome set. Methods: We searched the literature using 6 domestic databases. We selected studies that used Korean medicine interventions and targeted stroke patients with motor sequelae. We examined whether the included studies reported the stroke stage and whether they used the outcome measures in the appropriate period based on the recommendations of the "Stroke Evidence Database to Guide Effectiveness". We also confirmed the use of the essential assessment tools suggested by the core outcome set. Results: Overall, 77 studies were finally selected, with 16 (21%), 55 (71%), and 6 (8%) published on the acute, subacute, and chronic phases, respectively. Only 11 of the studies directly mentioned the stroke stage. The most commonly used assessments were the National Institutes of Health Stroke Scale, Modified Barthel Index, and Manual Muscle Testing. Only 5 studies failed to apply the stage-related outcome measures at the recommended period. The outcome variables used inadequately were the National Institutes of Health Stroke Scale, Functional Ambulation Categories, 36-Item Short Form Health Survey, and Mini-Mental State Examination. Among the core outcome set items, some studies used liver and renal function tests, but no herbal medicine safety reporting was conducted. Conclusions: In future studies, we propose to ensure accurate reporting of the stroke stage with reliable outcome measures to deliver better clinical and research outcomes. Furthermore, in future clinical studies on stroke, a standard protocol that reflects the core outcome set should be developed.